Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

A bit more

$X4 Pharmaceuticals(XFOR.US)$ FDA Approves X4 Pharmaceuticals' Xolremdi (Mavorixafor) Capsules For Use In Patients 12 Years Of Age And Older With WHIM Syndrome To Increase The Number Of Circulating Mature Neutrophils And Lymphocytes
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
3
+0
4
Translate
Report
7276 Views
Comment
Sign in to post a comment
2503Followers
28Following
33KVisitors
Follow